Search Results

There are 6019 results for: content related to: The pleiotropic actions of vitamin D

  1. You have free access to this content
    Program: First joint meeting of the American society for bone and mineral research and the international conferences on calcium regulating hormones

    Journal of Bone and Mineral Research

    Volume 4, Issue S1, August 1989, Pages: 1–419,

    Version of Record online : 3 DEC 2009, DOI: 10.1002/jbmr.5650040702

  2. You have free access to this content
    1,25-Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

    European Journal of Immunology

    Volume 41, Issue 10, October 2011, Pages: 2937–2946, Ji H. Lee, Sunyoung Park, Soyoung Cheon, Joo H. Lee, Sunghan Kim, Dae Y. Hur, Tae S. Kim, Suk R. Yoon, Yoolhee Yang, Sa I. Bang, Hyunjeong Park, Hoon T. Lee and Daeho Cho

    Version of Record online : 6 SEP 2011, DOI: 10.1002/eji.201141597

  3. You have free access to this content
    Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines

    Journal of Orthopaedic Research

    Volume 30, Issue 5, May 2012, Pages: 831–844, Lindsey Thompson, Shanshan Wang, Ossama Tawfik, Kimberly Templeton, Jakica Tancabelic, David Pinson, H. Clarke Anderson, John Keighley and Rama Garimella

    Version of Record online : 31 OCT 2011, DOI: 10.1002/jor.21585

  4. 1α,25-Dihydroxy-3-Epi-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion

    Journal of Cellular Biochemistry

    Volume 73, Issue 1, 1 April 1999, Pages: 106–113, A.J. Brown, C. Ritter, E. Slatopolsky, K.R. Muralidharan, W.H. Okamura and G.S. Reddy

    Version of Record online : 16 FEB 1999, DOI: 10.1002/(SICI)1097-4644(19990401)73:1<106::AID-JCB12>3.0.CO;2-Q

  5. You have free access to this content
    Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: Implications for drug-induced osteomalacia

    Journal of Bone and Mineral Research

    Volume 28, Issue 5, May 2013, Pages: 1101–1116, Zhican Wang, Yvonne S Lin, Leslie J Dickmann, Emma-Jane Poulton, David L Eaton, Johanna W Lampe, Danny D Shen, Connie L Davis, Margaret C Shuhart and Kenneth E Thummel

    Version of Record online : 17 APR 2013, DOI: 10.1002/jbmr.1839

  6. 1α,25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells

    Journal of Cellular Biochemistry

    Volume 113, Issue 4, April 2012, Pages: 1170–1181, Claudia G. Buitrago, Nadia S. Arango and Ricardo L. Boland

    Version of Record online : 23 FEB 2012, DOI: 10.1002/jcb.23444

  7. Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells

    Journal of Cellular Physiology

    Volume 176, Issue 3, September 1998, Pages: 574–587, Marla J. Steinbeck, Jung-Keun Kim, Mathew J. Trudeau, Peter V. Hauschka and Morris J. Karnovsky

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-4652(199809)176:3<574::AID-JCP14>3.0.CO;2-#

  8. Arachidonic acid is an autocoid mediator of the differential action of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes

    Journal of Cellular Physiology

    Volume 176, Issue 3, September 1998, Pages: 516–524, B. D. Boyan, V. L. Sylvia, D. Curry, Z. Chang, D. D. Dean and Z. Schwartz

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-4652(199809)176:3<516::AID-JCP8>3.0.CO;2-R

  9. You have free access to this content
    1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses

    Immunology

    Volume 130, Issue 2, June 2010, Pages: 181–192, Shelley Gorman, Melinda A. Judge, Jennifer T. Burchell, Debra J. Turner and Prue H. Hart

    Version of Record online : 6 JAN 2010, DOI: 10.1111/j.1365-2567.2009.03222.x

  10. You have free access to this content
    Protection against cyclophosphamide-induced alopecia and inhibition of mammary tumor growth by topical 1,25-dihydroxyvitamin D3 in mice

    International Journal of Cancer

    Volume 75, Issue 2, 19 January 1998, Pages: 303–309, Guan Chen, Alec Baechle, Thomas D. Nevins, Susan Oh, Charles Harmon and Dennis W. Stacey

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980119)75:2<303::AID-IJC21>3.0.CO;2-C

  11. 24R,25-(OH)2D3 mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A2 and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes

    Journal of Cellular Physiology

    Volume 182, Issue 3, March 2000, Pages: 390–401, Z. Schwartz, V.L. Sylvia, F. Del Toro, R.R. Hardin, D.D. Dean and B.D. Boyan

    Version of Record online : 31 JAN 2000, DOI: 10.1002/(SICI)1097-4652(200003)182:3<390::AID-JCP10>3.0.CO;2-T

  12. A-ring analogues of 1,25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation

    Journal of Cellular Physiology

    Volume 171, Issue 3, June 1997, Pages: 357–367, Daniel M. Greising, Zvi Schwartz, Gary H. Posner, Victor L. Sylvia, David D. Dean and Barbara D. Boyan

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-4652(199706)171:3<357::AID-JCP14>3.0.CO;2-7

  13. Recent Developments of 19-Nor-1,25-dihydroxyvitamin D3 Analogues

    ChemMedChem

    Volume 8, Issue 8, August 2013, Pages: 1249–1260, Can-Fei Zhang, Prof. Ren-Zhong Wan and Prof. Zhao-Peng Liu

    Version of Record online : 20 JUN 2013, DOI: 10.1002/cmdc.201300160

  14. You have free access to this content
    Notes

    Journal of Bone and Mineral Research

    Volume 8, Issue S1, August 1993, Pages: S115–S399,

    Version of Record online : 25 FEB 2010, DOI: 10.1002/jbmr.5650081350

  15. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice

    Biopharmaceutics & Drug Disposition

    Volume 34, Issue 7, October 2013, Pages: 402–416, Edwin C.Y. Chow, Matthew R. Durk, Han-Joo Maeng and K. Sandy Pang

    Version of Record online : 16 SEP 2013, DOI: 10.1002/bdd.1856

    Corrected by:

    Erratum: Erratum

    Vol. 35, Issue 2, 134, Version of Record online: 4 FEB 2014

  16. You have free access to this content
    ASBMR 22nd annual meeting

    Journal of Bone and Mineral Research

    Volume 15, Issue S1, September 2000, Pages: S1–S584,

    Version of Record online : 4 AUG 2011, DOI: 10.1002/jbmr.5650150102

  17. Structure–function relationships of vitamin D including ligand recognition by the vitamin D receptor

    Medicinal Research Reviews

    Volume 23, Issue 1, January 2003, Pages: 89–115, Sachiko Yamada, Masato Shimizu and Keiko Yamamoto

    Version of Record online : 7 NOV 2002, DOI: 10.1002/med.10023

  18. 1α,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway

    The Prostate

    Volume 59, Issue 3, 15 May 2004, Pages: 282–291, Shalini Murthy and Nancy L. Weigel

    Version of Record online : 22 DEC 2003, DOI: 10.1002/pros.10373

  19. 5α-dihydrotestosterone inhibits 1α,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells

    The Prostate

    Volume 63, Issue 3, 15 May 2005, Pages: 222–230, Yan-Ru Lou, Nadja Nazarova, Riikka Talonpoika and Pentti Tuohimaa

    Version of Record online : 10 NOV 2004, DOI: 10.1002/pros.20189

  20. Natural metabolites of 1α,25-dihydroxyvitamin D3 retain biologic activity mediated through the vitamin D receptor

    Journal of Cellular Biochemistry

    Volume 78, Issue 1, 1 July 2000, Pages: 112–120, H. Harant, D. Spinner, G.S. Reddy and I.J.D. Lindley

    Version of Record online : 26 APR 2000, DOI: 10.1002/(SICI)1097-4644(20000701)78:1<112::AID-JCB10>3.0.CO;2-7